Sort
48,018 grants matching “immunotherapy”
INTEGRATED ANALYSIS OF SOMATIC GENOMIC MUTATIONS AND ANTIGEN PRESENTATION AS PREDICTIVE BIOMARKERS FOR COMBINATION IMMUNOTHERAPY IN KIDNEY CANCER
$663,077Sloan-Kettering Institute For Cancer Research · · FY2020 · Defense Health Agency
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$662,979Dung T Le · Johns Hopkins University · P01 · FY2022 · CA
Immunobiology of Normal and Neoplastic Lymphocytes
$662,948Warren S Pear · University Of Pennsylvania · T32 · FY2023 · CA
Designer extracellular vesicles for cancer therapy
$662,946Xiaowei Xu · University Of Pennsylvania · R01 · FY2024 · CA
Regulatory T cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$662,913Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U19 · FY2019 · AI
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$662,835Albert Folch · University Of Washington · R01 · FY2025 · CA
T cell migration and cardiovascular toxicity in immunotherapy
$662,810Minsoo Kim · University Of Rochester · R01 · FY2025 · AI
Attacking the Immunopeptidome of Ewing Sarcoma
$662,764Crystal Mackall · Stanford University · U01 · FY2024 · CA
Structure-based inhibition of chemokine signaling in the inflamed pancreas
$662,744Brian F Volkman · Medical College Of Wisconsin · R01 · FY2023 · DK
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$662,729Robert H Vonderheide · University Of Pennsylvania · R01 · FY2018 · CA
Evolution of gliomas during treatment and resistance
$662,723Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$662,592Gerald V Denis · Boston University Medical Campus · U01 · FY2022 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$662,560Joshua Aiden Hill · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
Project 3: Integrative approach tounderstanding the mechanism ofcostimulation
$662,499Arlene H Sharpe · Yale University · P01 · FY2021 · AI
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$662,338Cesar M Castro · Massachusetts General Hospital · R01 · FY2021 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$662,308Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$662,209Richard J Price · University Of Virginia · R01 · FY2022 · EB
Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy
$662,209Richard J Price · University Of Virginia · R01 · FY2023 · EB
Neutralizing Botulinum Neurotoxin with Human Antibodies
$662,129Scott Fields · Sri International · U01 · FY2009 · AI
Mechanisms of immune homeostasis and regulation of intraocular inflammation
$662,056Charles E Egwuagu · National Eye Institute · ZIA · FY2023 · EY
Neoadjuvant Immunotherapy Platform Study Reveals Mechanisms of Response in Hepatocellular Carcinoma (HCC)
$662,037Mark Yarchoan · Johns Hopkins University · R01 · FY2024 · CA
Novel mouse models of hepatitis B virus infection and replication
$662,025Guangxiang George Luo · Wake Forest University Health Sciences · R01 · FY2024 · AI
Targeting STAT SUMOylation for HIV cure strategies
$661,944Alberto Bosque · George Washington University · R56 · FY2020 · AI
Evaluation of Neurobiological Mechanisms Mediating the Effect of Immune Activation on Neurocognitive Impairment and the Role of Psychosocial Factors Among Women Living with HIV
$661,886Pariya Fazeli Wheeler · University Of Alabama At Birmingham · R01 · FY2024 · MH
Therapy of Dengue with Modified Antibodies in Humanized Mice
$661,840Rebeca Rico-Hesse · Baylor College Of Medicine · R01 · FY2015 · AI